Stub

From HemOnc.org - A Hematology Oncology Wiki
Jump to navigation Jump to search

Regimens that have not proven to be superior to a standard-of-care comparison and are thus unlikely to be expanded upon unless new evidence comes forward. This page is primarily to drive the HemOnc Ontology and for historic interest.

Last updated on 2024-07-23:
410 regimens on this page
410 variants on this page


Regimens

3M

3M: Mitomycin, Mitoxantrone, Methotrexate

Regimen

Chemotherapy

4d+7

Regimen

Chemotherapy

4i+7

Regimen

Chemotherapy

5-FU & RT

Regimen

Chemotherapy

Radiotherapy

5-FU, Cyclophosphamide, Dactinomycin

Regimen

Chemotherapy

7+2d

Regimen

Chemotherapy

7+3a

Regimen

Chemotherapy

7+3d & Azacitidine

Regimen

Chemotherapy

7+3d & GM-CSF

Regimen

Chemotherapy

Growth factor therapy

7+3d & Zosuquidar

Regimen

Chemotherapy

7+3i & Clofarabine

7+3i & Clofarabine: 7 days of cytarabine, 3 days of idarubicin, Clofarabine

Regimen

Chemotherapy

7+3i & Lenalidomide

7+3i & Lenalidomide: 7 days of cytarabine, 3 days of idarubicin, Lenalidomide

Regimen

Chemotherapy

Targeted therapy

7+4d

Regimen

Chemotherapy

7+4i

7+4i: 7 days of cytarabine, 4 days of idarubicin

Regimen

Chemotherapy

7+5d

7+5d: 7 days of cytarabine, 5 days of daunorubicin

Regimen

Chemotherapy

7+5i & Quinine

Regimen

Chemotherapy

10+3d

Regimen

Chemotherapy

A-C

Regimen

Chemotherapy

A-CHOP-14

Regimen

Chemotherapy

Glucocorticoid therapy

Targeted therapy

A-D-CMF

Regimen

Chemotherapy

A-D

Regimen

Chemotherapy

A-ICE

A-ICE: ATRA, Idarubicin, Cytarabine, Etoposide

Regimen

Targeted therapy

Chemotherapy

Abiraterone & Enzalutamide

Regimen

Endocrine therapy

Abiraterone & Ipatasertib

Regimen

Endocrine therapy

Targeted therapy

Abiraterone, Radium-223, Prednisone

Regimen

Endocrine therapy

Radiotherapy

ABV

ABV: Adriamycin (Doxorubicin), Bleomycin, Vinblastine

Regimen

Chemotherapy

ABVP

ABVP: Adriamycin (Doxorubicin), Bleomycin, Vinblastine, Platinol (Cisplatin)

Regimen

Chemotherapy

AC-KP

Regimen

Chemotherapy

Targeted therapy

Antibody-drug conjugate therapy

Acalabrutinib & Venetoclax

Regimen

Targeted therapy

ACP

ACP: Atezolizumab, Carboplatin, Paclitaxel

Regimen

Immunotherapy

Chemotherapy

AD-CMF

Regimen

Chemotherapy

Adavosertib & Gemcitabine

Regimen

Targeted therapy

Chemotherapy

Afatinib & Vinorelbine

Regimen

Chemotherapy

Targeted therapy

Alisertib monotherapy

Regimen

Targeted therapy

Altretamine & Melphalan

Regimen

Chemotherapy

AME

AME: Ara-C (Cytarabine), Mitoxantrone, Etoposide

Regimen

Chemotherapy

Amonafide & Cytarabine

Regimen

Chemotherapy

Amrubicin & Cisplatin

Regimen

Chemotherapy

Amsacrine & Cytarabine

Regimen

Chemotherapy

Amsacrine & IDAC

Amsacrine & IDAC: Amsacrine & Intermediate Dose Ara-C (Cytarabine)

Regimen

Chemotherapy

Amsacrine monotherapy

Regimen

Chemotherapy

Anastrozole and Everolimus

Regimen

Endocrine therapy

Targeted therapy

Anastrozole and Lapatinib

Regimen

Endocrine therapy

Targeted therapy

Anastrozole and Tamoxifen

Regimen

Endocrine therapy

Anlotinib monotherapy

Regimen

Targeted therapy

API

API: Adriamycin (Doxorubicin), Platinol (Cisplatin), Ifosfamide

Regimen

Chemotherapy

Atezolizumab & RT

Regimen

Immunotherapy

Radiotherapy

ATRA, Cytarabine, Etoposide

Regimen

Targeted therapy

Chemotherapy

AVML

AVML: Ara-C (Cytarabine), Vincristine, Methotrexate, Leucovorin

Regimen

Chemotherapy

Supportive therapy

Axitinb & Toripalimab

Regimen

Immunotherapy

Targeted therapy

Azacitidine & Eltrombopag

Regimen

Chemotherapy

Growth factor therapy

Azacitidine & Gilteritinib

Regimen

Chemotherapy

Targeted therapy

Barasertib & LoDAC

Regimen

Chemotherapy

Targeted therapy

Binimetinib monotherapy

Regimen

Targeted therapy

Bortezomib & Bevacizumab

Regimen

Study Dates of enrollment Evidence Comparator Comparative Efficacy
White et al. 2012 (AMBER) 2007-2009 Randomized Phase 2 (E-esc) Bortezomib Did not meet primary endpoint of PFS
(HR 0.74, 95% CI 0.43-1.28)

Targeted therapy

Bortezomib & Siltuximab

Regimen

Study Dates of enrollment Evidence Comparator Comparative Efficacy
Orlowski et al. 2015 (CR012784) 2006-2009 Randomized Phase 2 (E-esc) Bortezomib Did not meet primary endpoint of PFS
(HR 0.87, 95% CI 0.65-1.16)

Targeted therapy

Immunosuppressive therapy

BTH (Docetaxel)

BTH: Bevacizumab, Taxotere (Docetaxel), Herceptin (Trastuzumab)

Regimen

Chemotherapy

Targeted therapy

BTOC

BTOC: BCNU, Thiotepa, Oncovin (Vincristine), Cyclophosphamide

Regimen

Chemotherapy

Buparlisib & Fulvestrant

Regimen

Targeted therapy

Endocrine therapy

Buparlisib & Paclitaxel

Regimen

Targeted therapy

Chemotherapy

CAD

CAD: Cyclophosphamide, Adriamycin (Doxorubicin), DDP (Cisplatin)

Regimen

Chemotherapy

Capecitabine & Cisplatin (CX) & Bevacizumab

Regimen

Chemotherapy

Targeted therapy

Capecitabine & Cisplatin (CX) & Ramucirumab

Regimen

Chemotherapy

Targeted therapy

Capecitabine & Cisplatin (CX) & Simvastatin

Regimen

Chemotherapy

Targeted therapy

Capecitabine & Cisplatin (CX), Durvalumab, RT

Regimen

Chemotherapy

Immunotherapy

Radiotherapy

Capecitabine & Docetaxel (TX) & Bevacizumab

Regimen

Chemotherapy

Targeted therapy

Capecitabine & Paclitaxel (XP)

Regimen

Chemotherapy

Capecitabine & Ruxolitinib

Regimen

Chemotherapy

Targeted therapy

Capecitabine & Sorafenib

Regimen

Chemotherapy

Targeted therapy

Capecitabine & Sunitinib

Regimen

Chemotherapy

Targeted therapy

Capecitabine & Vinflunine

Regimen

Chemotherapy

Capecitabine & Vinorelbine (NX)

NX: Navelbine (Vinorelbine) & Xeloda (Capecitabine)

Regimen

Chemotherapy

Capecitabine, Cisplatin, Cetuximab, RT

Regimen

Chemotherapy

Targeted therapy

Radiotherapy

Capecitabine, Erlotinib, RT

Regimen

Chemotherapy

Targeted therapy

Radiotherapy

CapeOx & Cediranib

Regimen

Chemotherapy

Targeted therapy

CapeOx & Cetuximab

Regimen

Chemotherapy

Targeted therapy

CapeOx & Lapatinib

Regimen

Chemotherapy

Targeted therapy

CapeOx & RT

Regimen

Chemotherapy

Radiotherapy

CapeOx & Tislelizumab

Regimen

Chemotherapy

Immunotherapy

CapeOx, Bevacizumab, Cetuximab

Regimen

Chemotherapy

Targeted therapy

Capivasertib & Fulvestrant

Regimen

Endocrine therapy

Targeted therapy

CarboMIP

CarboMIP: Carboplatin, Mitomycin, Ifosfamide, Platinol (Cisplatin)

Regimen

Chemotherapy

Carboplatin & Docetaxel (DCb) & Bevacizumab

Regimen

Chemotherapy

Targeted therapy

Carboplatin & Docetaxel (DCb) & Celecoxib

Regimen

Chemotherapy

Carboplatin & Docetaxel (DCb) & Cetuximab

Regimen

Chemotherapy

Targeted therapy

Carboplatin & Docetaxel (DCb) & Farletuzumab

Regimen

Chemotherapy

Targeted therapy

Carboplatin & Docetaxel (DCb) & RT

Regimen

Chemotherapy

Radiotherapy

Carboplatin & Doxorubicin

Regimen

Chemotherapy

Carboplatin & Epirubicin

Regimen

Chemotherapy

Carboplatin & Etoposide (CE) & Adebrelimab

Regimen

Chemotherapy

Targeted therapy

Carboplatin & Etoposide (CE) & Ipilimumab

CE & Ipilimumab: Carboplatin, Etoposide, Ipilimumab

Regimen

Chemotherapy

Immunotherapy

Carboplatin & Etoposide (CE) & Pravastatin

Regimen

Chemotherapy

Targeted therapy

Carboplatin & Etoposide (CE) & Thalidomide

CE & Thalidomide: Carboplatin, Etoposide, Thalidomide

Regimen

Chemotherapy

Targeted therapy

Carboplatin & Etoposide (CE), then auto HSCT

Regimen

Chemotherapy

Carboplatin & Gemcitabine (GCb) & Celecoxib

Regimen

Chemotherapy

Targeted therapy

Carboplatin & Gemcitabine (GCb) & Gefitinib

Regimen

Chemotherapy

Targeted therapy

Carboplatin & Gemcitabine (GCb), Atezolizumab, Bevacizumab

Regimen

Chemotherapy

Immunotherapy

Targeted therapy

Carboplatin & Gemcitabine (GCb)/Erlotinib

Regimen

Chemotherapy

Targeted therapy

Carboplatin & Paclitaxel (CP) & Agatolimod

Regimen

Chemotherapy

Targeted therapy

Carboplatin & Paclitaxel (CP) & Atezolizumab

Regimen

Chemotherapy

Immunotherapy

Carboplatin & Paclitaxel (CP) & Avelumab

Regimen

Chemotherapy

Immunotherapy

Carboplatin & Paclitaxel (CP) & Bexarotene

CP & Bexarotene: Carboplatin, Paclitaxel, Bexarotene

Regimen

Chemotherapy

Targeted therapy

Carboplatin & Paclitaxel (CP) & Cediranib

CP & Cediranib: Carboplatin, Paclitaxel, Cediranib

Regimen

Chemotherapy

Targeted therapy

Carboplatin & Paclitaxel (CP) & Celecoxib

Regimen

Chemotherapy

Targeted therapy

Carboplatin & Paclitaxel (CP) & Cetuximab

CP & Cetuximab: Carboplatin, Paclitaxel, Cetuximab

Regimen

Chemotherapy

Targeted therapy

Carboplatin & Paclitaxel (CP) & Erlotinib

CP & Erlotinib: Carboplatin, Paclitaxel, Erlotinib

Regimen

Chemotherapy

Targeted therapy

Carboplatin & Paclitaxel (CP) & Farletuzumab

Regimen

Chemotherapy

Targeted therapy

Carboplatin & Paclitaxel (CP) & Figitumumab

Regimen

Chemotherapy

Targeted therapy

Carboplatin & Paclitaxel (CP) & Gefitinib

Regimen

Chemotherapy

Targeted therapy

Carboplatin & Paclitaxel (CP) & Interferon gamma-1b

Regimen

Chemotherapy

Immunotherapy

Carboplatin & Paclitaxel (CP) & Motesanib

Regimen

Chemotherapy

Targeted therapy

Carboplatin & Paclitaxel (CP) & Pegylated liposomal doxorubicin

CP & PLD: Carboplatin, Paclitaxel, Pegylated Liposomal Doxorubicin
TC & PLD: Taxol (Paclitaxel), Carboplatin, Pegylated Liposomal Doxorubicin

Regimen

Chemotherapy

Carboplatin & Paclitaxel (CP) & Rebimastat

Regimen

Chemotherapy

Targeted therapy

Carboplatin & Paclitaxel (CP) & Sorafenib

CP & Sorafenib: Carboplatin, Paclitaxel, Sorafenib

Regimen

Chemotherapy

Targeted therapy

Carboplatin & Paclitaxel (CP) & Tirapazamine

Regimen

Chemotherapy

Carboplatin & Paclitaxel (CP) & Topotecan

TC & Topotecan: Taxol (Paclitaxel), Carboplatin, Topotecan

Regimen

Chemotherapy

Carboplatin & Paclitaxel (CP) & Trebananib

TC & Trebananib: Taxol (Paclitaxel), Carboplatin, Trebananib

Regimen

Study Dates of enrollment Evidence Comparator Comparative Efficacy
Vergote et al. 2019 (TRINOVA-3) 2012-2014 Phase 3 (E-esc) TC Did not meet primary endpoint of PFS
(HR 0.93, 95% CI 0.79-1.09)

Chemotherapy

Targeted therapy

Carboplatin & Paclitaxel (CP) & Vadimezan

CP & Vadimezan: Carboplatin, Paclitaxel, Vadimezan

Chemotherapy

Targeted therapy

Carboplatin & Paclitaxel (CP) & Veliparib

CP & Veliparib: Carboplatin, Paclitaxel, Veliparib

Regimen

Chemotherapy

Targeted therapy

Carboplatin & Paclitaxel (CP), Atezolizumab, Bevacizumab

Regimen

Chemotherapy

Immunotherapy

Targeted therapy

Carboplatin & Paclitaxel (CP), Bevacizumab, Cetuximab

Regimen

Chemotherapy

Targeted therapy

Carboplatin & Paclitaxel (CP), Cetuximab, RT

Regimen

Chemotherapy

Targeted therapy

Radiotherapy

Carboplatin & Topotecan

Regimen

Chemotherapy

Carboplatin, Docetaxel, RT

Regimen

Chemotherapy

Radiotherapy

Carboplatin, Durvalumab, RT

Regimen

Chemotherapy

Immunotherapy

Radiotherapy

Carboplatin, Etoposide, Melphalan

Regimen

Chemotherapy

Carboplatin, Fluorouracil, Bevacizumab

Regimen

Chemotherapy

Targeted therapy

Carboplatin, Gemcitabine, Bevacizumab

Regimen

Chemotherapy

Targeted therapy

Carboplatin, Irinotecan, RT

Regimen

Chemotherapy

Radiotherapy

Carboplatin, Lenvatinib, Pemetrexed, Pembrolizumab

Regimen

Chemotherapy

Immunotherapy

Targeted therapy

Carboplatin, Paclitaxel, Trastuzumab, RT

Regimen

Chemotherapy

Targeted therapy

Radiotherapy

Carboplatin, Vindesine, RT

Regimen

Chemotherapy

Radiotherapy

Carfilzomib & Ibrutinib

Regimen

Targeted therapy

Carmustine, Cisplatin, RT

Regimen

Chemotherapy

Radiotherapy

CAVE & RT

Regimen

Chemotherapy

Radiotherapy

CBM

CBM: Capecitabine, Bevacizumab, Mitomycin

Regimen

Chemotherapy

Targeted therapy

CCG

CCG: Cisplatin, Carboplatin, Gemcitabine

Regimen

Chemotherapy

Cediranib monotherapy

Regimen

Targeted therapy

Chlorambucil, Cisplatin, Doxorubicin

Regimen

Chemotherapy

ChlVPP/EVA

ChlVPP/EVA: Chlorambucil, Vinblastine, Procarbazine, Prednisone alternating with Etoposide, Vincristine, Adriamycin (Doxorubicin)

Regimen

Chemotherapy, ChlVPP portion

Glucocorticoid therapy, ChlVPP portion

Chemotherapy, EVA portion

CIB

CIB: Cisplatin, Ifosfamide, Bleomycin

Regimen

Chemotherapy

Cisplatin & Docetaxel (DC) & Bevacizumab

Regimen

Chemotherapy

Targeted therapy

Cisplatin & Docetaxel (DC) & Cetuximab

Regimen

Chemotherapy

Targeted therapy

Cisplatin & Etoposide (EP) & Paclitaxel

Regimen

Chemotherapy

Cisplatin & Etoposide (EP) & Pravastatin

Regimen

Chemotherapy

Cisplatin & Etoposide (EP) & RT

Regimen

Chemotherapy

Radiotherapy

Cisplatin & Etoposide (EP)/Topotecan monotherapy

Regimen

Chemotherapy

Cisplatin & Fluorouracil (CF) & Bevacizumab

Regimen

Chemotherapy

Targeted therapy

Cisplatin & Fluorouracil (CF), Durvalumab, RT

Regimen

Chemotherapy

Immunotherapy

Radiotherapy

Cisplatin & Fluorouracil (CF), Interferon alfa-2b, RT

Regimen

Chemotherapy

Immunotherapy

Radiotherapy

Cisplatin & Fluorouracil (CF), Lenvatinib, Pembrolizumab

Regimen

Chemotherapy

Immunotherapy

Targeted therapy

Cisplatin & Fluorouracil (CF), Pembrolizumab, Trastuzumab

Regimen

Chemotherapy

Immunotherapy

Targeted therapy

Cisplatin & Gemcitabine (GC) & Erlotinib

GC & Erlotinib: Gemcitabine, Cisplatin, Erlotinib

Regimen

Chemotherapy

Targeted therapy

Cisplatin & Gemcitabine (GC) & Gefitinib

GC & Gefitinib: Gemcitabine, Cisplatin, Gefitinib

Regimen

Chemotherapy

Targeted therapy

Cisplatin & Gemcitabine (GC) & Nadroparin

GC & Nadroparin: Gemcitabine, Cisplatin, Nadroparin

Regimen

Chemotherapy

Anticoagulation

Cisplatin & Gemcitabine (GC) & Sorafenib

GC & Sorafenib: Gemcitabine, Cisplatin, Sorafenib

Regimen

Chemotherapy

Targeted therapy

Cisplatin & Gemcitabine (GC) & Tislelizumab

GC & Tislelizumab: Gemcitabine, Cisplatin, Tislelizumab

Regimen

Chemotherapy

Immunotherapy

Cisplatin & Gemcitabine (GC) & Veliparib

GC & Veliparib: Gemcitabine, Cisplatin, Veliparib

Regimen

Chemotherapy

Targeted therapy

Cisplatin & Irinotecan (IC) & Cetuximab

Regimen

Chemotherapy

Targeted therapy

Cisplatin & Methotrexate

Regimen

Chemotherapy

Cisplatin & Treosulfan

Regimen

Chemotherapy

Cisplatin & Vincristine

Regimen

Chemotherapy

Cisplatin, Avelumab, RT

Regimen

Chemotherapy

Immunotherapy

Radiotherapy

Cisplatin, Durvalumab, RT

Regimen

Chemotherapy

Immunotherapy

Radiotherapy

Cisplatin, Fluorouracil, Vinblastine, RT

Regimen

Chemotherapy

Radiotherapy

Cisplatin, Lapatinib, RT

Regimen

Chemotherapy

Targeted therapy

Radiotherapy

Cisplatin, Nintedanib, Pemetrexed

Regimen

Chemotherapy

Targeted therapy

Cisplatin & Paclitaxel (TP), Cetuximab, RT

Regimen

Chemotherapy

Targeted therapy

Radiotherapy

Cisplatin & Paclitaxel (TP), Erlotinib, RT

Regimen

Chemotherapy

Targeted therapy

Radiotherapy

Cisplatin & Paclitaxel (TP), Lenvatinib, Pembrolizumab

Regimen

Chemotherapy

Immunotherapy

Targeted therapy

Cisplatin & Paclitaxel (TP), Tislelizumab, RT

Regimen

Chemotherapy

Immunotherapy

Radiotherapy

Cisplatin, Pemetrexed, Gefitinib

Regimen

Study Dates of enrollment Evidence Comparator Comparative Efficacy
Soria et al. 2015 (IMPRESS) 2012-2013 Phase 3 (E-esc) Cisplatin & Pemetrexed Did not meet primary endpoint of PFS
Median PFS: 5.4 vs 5.4 mo
(HR 0.86, 95% CI 0.65-1.13)

Chemotherapy

Targeted therapy

Cisplatin, Pemetrexed, RT

Regimen

Chemotherapy

Radiotherapy

Cisplatin, Tirapazamine, RT

Regimen

Chemotherapy

Radiotherapy

Cisplatin, Vinorelbine, Bevacizumab

Regimen

Chemotherapy

Targeted therapy

CMF & RT

Regimen

Chemotherapy

Radiotherapy

CODE

CODE: Cisplatin, Oncovin (Vincristine), Doxorubicin, Etoposide

Regimen

Chemotherapy

COPPEBVCAD

COPPEBVCAD: Cyclophosphamide, Oncovin (Vincristine), Procarbazine, Prednisone, Epirubicin, Bleomycin, Vinblastine, CCNU (Lomustine), Alkeran (Melphalan), DVA (Vindesine)

Regimen

Chemotherapy

Glucocorticoid therapy

Cyclophosphamide & RT

Regimen

Chemotherapy

Radiotherapy

Cyclophosphamide & Thiotepa, then auto HSCT

Regimen

Chemotherapy

Cyclophosphamide & Thiotepa

Regimen

Chemotherapy

Cyclophosphamide & Vincristine (CV)

Regimen

Chemotherapy

Cyclophosphamide, Dacarbazine, Doxorubicin

Regimen

Chemotherapy

Cyclophosphamide, Dactinomycin, Fluorouracil

Regimen

Chemotherapy

Cyclophosphamide, Daunorubicin, Vincristine, Dexamethasone

Regimen

Chemotherapy

Glucocorticoid therapy

Cyclophosphamide, DES, Fluorouracil

Regimen

Chemotherapy

Endocrine therapy

Cyclophosphamide, Etoposide, Lestaurtinib, Methotrexate

Regimen

Chemotherapy

Targeted therapy

Cyclophosphamide, Etoposide, TBI, then auto HSCT

Regimen

Chemotherapy

Radiotherapy

Cyclophosphamide, Mitoxantrone, Thiotepa, then auto HSCT

Regimen

Chemotherapy

Cyclophosphamide, Mitoxantrone, Thiotepa

Regimen

Chemotherapy

Cytarabine & Ifosfamide

Regimen

Chemotherapy

Cytarabine & Imatinib

Regimen

Chemotherapy

Targeted therapy

CYVADIC

CYVADIC: CYclophosphamide, Vincristine, ADriamycin (Doxorubicin), Imidazole Carboxamide (Dacarbazine)

Regimen

Chemotherapy

Dacarbazine & Dactinomycin

Regimen

Chemotherapy

Dacarbazine & Fotemustine

Regimen

Chemotherapy

Dacarbazine & Interferon alfa-2b

Regimen

Chemotherapy

Immunotherapy

Dacarbazine & RT

Regimen

Chemotherapy

Radiotherapy

Dacarbazine & Selumetinib

Regimen

Chemotherapy

Targeted therapy

Dacarbazine & Vindesine

Regimen

Chemotherapy

Dacarbazine, Fluorouracil, Semustine, Vincristine

Regimen

Chemotherapy

Dacarbazine, Fluorouracil, Semustine

Regimen

Chemotherapy

Dacarbazine, Fotemustine, Interferon alfa-2b

Regimen

Chemotherapy

Immunotherapy

Dacarbazine, Interferon alfa-2b, Tamoxifen

Regimen

Chemotherapy

Endocrine therapy

Immunotherapy

Dactinomycin, Doxorubicin, Vincristine

Regimen

Chemotherapy

DBCT

DBCT: Dacarbazine, BCNU (Carmustine), Cisplatin, Tamoxifen

Regimen

Chemotherapy

Endocrine therapy

ddAC-KP

Regimen

Chemotherapy

Targeted therapy

Antibody-drug conjugate therapy

ddEC-KP

Regimen

Chemotherapy

Targeted therapy

Antibody-drug conjugate therapy

ddFEC

ddFEC: dose-dense Fluorouracil, Epirubicin, Cyclophosphamide

Regimen

Chemotherapy

Supportive therapy

Dinaciclib monotherapy

Regimen

Targeted therapy

Docetaxel & Bavituximab

Regimen

Chemotherapy

Immunotherapy

Docetaxel & Erlotinib

Regimen

Chemotherapy

Targeted therapy

Docetaxel & Fluorouracil

Regimen

Chemotherapy

Docetaxel & Ganetespib

Regimen

Chemotherapy

Targeted therapy

Docetaxel & Gefitinib

Regimen

Chemotherapy

Targeted therapy

Docetaxel & Lapatinib (TL)

Regimen

Chemotherapy

Targeted therapy

Docetaxel & Leuprolide

Regimen

Chemotherapy

Endocrine therapy

Docetaxel & Pertuzumab

Regimen

Chemotherapy

Targeted therapy

Docetaxel & Selumetinib

Regimen

Chemotherapy

Targeted therapy

Docetaxel & Sunitinib

Regimen

Chemotherapy

Targeted therapy

Docetaxel & Ziv-aflibercept

Regimen

Chemotherapy

Targeted therapy

Docetaxel, Lenalidomide, Prednisone

Regimen

Chemotherapy

Endocrine therapy

Targeted therapy

Docetaxel, Prednisone, Bevacizumab

Regimen

Chemotherapy

Endocrine therapy

Targeted therapy

Doxorubicin & Etoposide

Regimen

Chemotherapy

Doxorubicin & Paclitaxel

Regimen

Chemotherapy

Doxorubicin & Sorafenib

Regimen

Chemotherapy

Targeted therapy

Doxorubicin & Streptozocin

Regimen

Chemotherapy

Doxorubicin & Vinblastine (AV)

AV: Adriamycin (Doxorubicin) & Vinblastine

Regimen

Chemotherapy

Doxorubicin & Vinorelbine

Regimen

Chemotherapy

Durvalumab & RT

Regimen

Immunotherapy

Radiotherapy

E-GEMOX

E-GEMOX: Erlotinib, GEMcitabine, OXaliplatin

Regimen

Targeted therapy

Chemotherapy

EAP

EAP: Etoposide, Adriamycin (Doxorubicin), Platinol (Cisplatin)

Regimen

Chemotherapy

EC-KP

Regimen

Chemotherapy

Targeted therapy

Antibody-drug conjugate therapy

EC-TL (Docetaxel)

EC-TL: Epirubicin & Cyclophosphamide, followed by Taxotere (Docetaxel) & Lapatinib
EC-DL: Epirubicin & Cyclophosphamide, followed by Docetaxel & Lapatinib

Regimen

Chemotherapy, EC portion

Chemotherapy, TL portion

Targeted therapy, TL portion

ECVBP

ECVBP: Epirubicin, Cyclophosphamide, Vindesine, Bleomycin, Prednisone

Regimen

Chemotherapy

Glucocorticoid therapy

ECX & Bevacizumab

Regimen

Chemotherapy

Targeted therapy

ELF

ELF: Etoposide, Leucovorin, 5-FU (Fluorouracil)

Regimen

Chemotherapy

ELFE

ELFE: Etoposide, Leucovorin, 5-FU (Fluorouracil), Epirubicin

Regimen

Chemotherapy

Encorafenib monotherapy

Regimen

Targeted therapy

EP & Ipilimumab

EP & Ipilimumab: Etoposide, Platinol (Cisplatin), Ipilimumab

Regimen

Chemotherapy

Immunotherapy

EP, Tamoxifen, RT

EP, Tamoxifen, RT: Etoposide, Platinol (Cisplatin), Tamoxifen, Radiation Therapy

Regimen

Chemotherapy

Endocrine therapy

Radiotherapy

Epirubicin & Fluorouracil

Regimen

Chemotherapy

Epirubicin & Gemcitabine

Regimen

Chemotherapy

Epirubicin & Mitomycin (EM)

Regimen

Chemotherapy

Epirubicin & Tamoxifen

Regimen

Chemotherapy

Endocrine therapy

Epirubicin & Vindesine

Regimen

Chemotherapy

Erlotinib & Figitumumab

Regimen

Targeted therapy

Erlotinib & Onartuzumab

Regimen

Targeted therapy

Erlotinib & Sorafenib

Regimen

Targeted therapy

Erlotinib & Sunitinib

Regimen

Targeted therapy

Erlotinib & Tivantinib

Regimen

Targeted therapy

Erlotinib, Bevacizumab, Panitumumab

Regimen

Targeted therapy

Erlotinib, Gemcitabine, Bevacizumab

Regimen

Chemotherapy

Targeted therapy

Everolimus & Letrozole

Regimen

Endocrine therapy

Targeted therapy

Everolimus & Paclitaxel

Regimen

Chemotherapy

Targeted therapy

Everolimus & Sorafenib

Regimen

Targeted therapy

Everolimus & Vinorelbine

Regimen

Chemotherapy

Targeted therapy

Everolimus & Vorolanib

Regimen

Targeted therapy

Exemestane & Lapatinib

Regimen

Endocrine therapy

Targeted therapy

Exemestane & Palbociclib

Regimen

Endocrine therapy

Targeted therapy

FAP

FAP: Fluorouracil, Alfa interferon, Platinol (Cisplatin)

Regimen

Chemotherapy

Immunotherapy

FEC & HP

FEC & HP: Fluorouracil, Epirubicin, Cyclophosphamide, Herceptin (Trastuzumab), Pertuzumab

Regimen

Chemotherapy

Targeted therapy

FEC-KP

Regimen

Chemotherapy

Targeted therapy

Antibody-drug conjugate therapy

FLA

FLA: FLudarabine & Ara-C (Cytarabine)

Regimen

Chemotherapy

FLAG-Ida & GO

FLAG-Ida & GO: FLudarabine, Ara-C (Cytarabine), G-CSF (Lenograstim), Idarubicin, Gemtuzumab Ozogamicin

Regimen {{#subobject:44e85e|Variant=1}}

Chemotherapy

Growth factor therapy

Antibody-drug conjugate therapy

FLAI

FLAI: FLudarabine, Ara-C (Cytarabine), Idarubicin
FIA: Fludarabine, Idarubicin, Ara-C (Cytarabine)

Regimen

Chemotherapy

Fluorouracil & Gemcitabine

Regimen

Chemotherapy

Fluorouracil & Interferon alfa-2a

Regimen

Chemotherapy

Immunotherapy

Fluorouracil & Interferon alfa-2b

Regimen

Chemotherapy

Immunotherapy

Fluorouracil & Melphalan

Regimen

Chemotherapy

Fluorouracil & Vinorelbine

Regimen

Chemotherapy

Fluorouracil, Interferon alfa-2a, Interleukin-2

Regimen

Chemotherapy

Immunotherapy

Fluorouracil, Levamisole, RT

Regimen

Chemotherapy

Immunotherapy

Radiotherapy

Fluorouracil, Olaparib, Bevacizumab

Regimen

Chemotherapy

Targeted therapy

Fluorouracil, Semustine, RT

Regimen

Chemotherapy

Radiotherapy

Fluorouracil, Semustine, Vincristine

Regimen

Chemotherapy

FNC & RT

Regimen

Chemotherapy

Radiotherapy

FOLF-CB

FOLF-CB: FOLinic acid (Leucovorin), Fluorouracil, Cetuximab, Bevacizumab

Regimen

Chemotherapy

Targeted therapy

FOLFIRI & Regorafenib

FOLFIRI & Regorafenib: FOLinic acid (Leucovorin), Fluorouracil, IRInotecan, Regorafenib

Regimen

Chemotherapy

Targeted therapy

FOLFIRI & Simvastatin

FOLFIRI & Simvastatin: FOLinic acid (Leucovorin), Fluorouracil, IRInotecan, Simvastatin

Regimen

Chemotherapy

Targeted therapy

FOLFIRI & Sunitinib

FOLFIRI & Sunitinib: FOLinic acid (Leucovorin), Fluorouracil, IRInotecan, Sunitinib

Regimen

Chemotherapy

Targeted therapy

FOLFIRI, Bevacizumab, Cetuximab

Regimen

Chemotherapy

Targeted therapy

FOLFOX4 & Cediranib

Regimen

Chemotherapy

Targeted therapy

FULV & Cisplatin

FULV & Cisplatin: 5-FU, LeucoVorin, Cisplatin

Regimen

Chemotherapy

FULV & Edrecolomab

FULV & Edrecolomab: 5-FU, LeucoVorin, Edrecolomab

Regimen

Chemotherapy

Targeted therapy

FULV & Interferon alfa-2a

FULV & Interferon alfa-2a: 5-FU, LeucoVorin, Interferon alfa-2a

Regimen

Chemotherapy

Immunotherapy

FULV & Interferon alfa-2b

FULV & Interferon alfa-2b: 5-FU, LeucoVorin, Interferon alfa-2b

Regimen

Chemotherapy

Immunotherapy

FULV & Interferon alfa-2c

FULV & Interferon alfa-2c: 5-FU, LeucoVorin, Interferon alfa-2c

Regimen

Chemotherapy

Immunotherapy

FULV & Interleukin-2

Regimen

Chemotherapy

Immunotherapy

FULV & Trimetrexate

FULV & Trimetrexate: 5-FU, LeucoVorin, Trimetrexate

Regimen

Chemotherapy

Fulvestrant & Bevacizumab

Regimen

Endocrine therapy

Targeted therapy

Fulvestrant & Lapatinib

Regimen

Endocrine therapy

Targeted therapy

Gefitinib & Simvastatin

Regimen

Chemotherapy

Targeted therapy

Gemcitabine & Axitinib

Regimen

Chemotherapy

Targeted therapy

Gemcitabine & Cetuximab

Regimen

Chemotherapy

Targeted therapy

Gemcitabine & Cisplatin (GC) & LD IL-2

Regimen

Chemotherapy

Immunotherapy

Gemcitabine & Ganitumab

Regimen

Chemotherapy

Targeted therapy

Gemcitabine & Irinotecan (IG)

Regimen

Chemotherapy

Gemcitabine & Masitinib

Regimen

Chemotherapy

Targeted therapy

Gemcitabine & Pemetrexed

Regimen

Chemotherapy

Gemcitabine & Pertuzumab

Regimen

Chemotherapy

Targeted therapy

Gemcitabine & Sorafenib

Regimen

Chemotherapy

Targeted therapy

Gemcitabine & Topotecan

Regimen

Chemotherapy

Gemcitabine & Treosulfan

Regimen

Chemotherapy

Gemcitabine & Vandetanib

Regimen

Chemotherapy

Targeted therapy

Gemcitabine & Vinorelbine (GN)

Regimen

Chemotherapy

Gemcitabine & Vismodegib

Regimen

Chemotherapy

Targeted therapy

Gemcitabine & Ziv-aflibercept

Regimen

Chemotherapy

Targeted therapy

Glasdegib monotherapy

Regimen

Targeted therapy

GVP

GVP: Gemcitabine, Vinorelbine, Platinol (Cisplatin)

Regimen

Chemotherapy

HiDAC & Etoposide

Regimen

Chemotherapy

HiDAC & Mitoxantrone

Regimen

Chemotherapy

HiDAC & Quizartinib

Regimen

Chemotherapy

Targeted therapy

HiDAC & Sorafenib

Regimen

Chemotherapy

Targeted therapy

HiDAC+3d

Regimen

Chemotherapy

HiDAC+3i

Regimen

Chemotherapy

ICE, ATRA, GO

ICE, ATRA, GO: Idarubicin, Cytarabine, Etoposide, All-Trans Retinoic Acid, Gemtuzumab Ozogamicin

Regimen

Chemotherapy

Targeted therapy

Antibody-drug conjugate therapy

IFL & RT

Regimen

Chemotherapy

Radiotherapy

Interferon alfa-2a & Temsirolimus

Regimen

Immunotherapy

Targeted therapy

Interferon alfa-2a & Vinblastine

Regimen

Chemotherapy

Immunotherapy

Interferon gamma-1b monotherapy

Regimen

Immunotherapy

Ipatasertib & Paclitaxel

Regimen

Chemotherapy

Targeted therapy

Ixabepilone & Bevacizumab

Regimen

Chemotherapy

Targeted therapy

Lenalidomide & Rituximab (R2) & Tafasitamab

Regimen

Targeted therapy

Lenvatinib & Atezolizumab

Regimen

Immunotherapy

Targeted therapy

Letrozole & Everolimus

Regimen

Endocrine therapy

Targeted therapy

Letrozole & Temsirolimus

Regimen

Endocrine therapy

Targeted therapy

Levamisole & RT

Regimen

Immunotherapy

Radiotherapy

Lobaplatin & RT

Regimen

Chemotherapy

Radiotherapy

LoDAC & Volasertib

Regimen

Chemotherapy

Targeted therapy

LoDAC & Vosaroxin

Regimen

Chemotherapy

Lomustine & RT

Regimen

Chemotherapy

Radiotherapy

Lomustine, Melphalan, TBI, then auto HSCT

Regimen

Chemotherapy

Radiotherapy

Lomustine, Melphalan, TBI

Regimen

Chemotherapy

Radiotherapy

ME

ME: Mitoxantrone & Etoposide

Regimen

Chemotherapy

Mechlorethamine & RT

Regimen

Chemotherapy

Radiotherapy

Melphalan & Busulfan, then auto HSCT

Regimen

Chemotherapy

Melphalan & Busulfan

Regimen

Chemotherapy

Melphalan & TBI, then auto HSCT

Regimen

Chemotherapy

Radiotherapy

MEV

MEV: Mitomycin, Etoposide, Vindesine

Regimen

Chemotherapy

MFL

MFL: Methyl-lomustine (MeCCNU), 5-FU, Leucovorin

Regimen

Chemotherapy

mFOLFOX6, Atezolizumab, Bevacizumab

Regimen

Chemotherapy

Immunotherapy

Targeted therapy

mFOLFOX6, Bevacizumab, Cetuximab

Regimen

Chemotherapy

Targeted therapy

mFOLFOX6, Bevacizumab, Panitumumab

Regimen

Chemotherapy

Targeted therapy

mFOLFOX6, Lenvatinib, Pembrolizumab

Regimen

Chemotherapy

Immunotherapy

Targeted therapy

mFOLFOXIRI & Panitumumab

Regimen

Chemotherapy

Targeted therapy

MFT

MFL: Methotrexate, 5-FU, Tamoxifen

Regimen

Chemotherapy

Endocrine therapy

mini-CHVP

Regimen

Chemotherapy

Glucocorticoid therapy

Mitomycin & RT

Regimen

Chemotherapy

Radiotherapy

Mitomycin & Vinblastine

Regimen

Chemotherapy

Mitoxantrone & Hydrocortisone

Regimen

Chemotherapy

Endocrine therapy

Mitoxantrone, Vincristine, Prednisolone

Regimen

Chemotherapy

Glucocorticoid therapy

MMF

MMF: Methyl-lomustine (MeCCNU), Mitomycin, 5-FU

Regimen

Chemotherapy

MOPPEBVCAD

MOPPEBVCAD: Mechlorethamine, Oncovin (Vincristine), Procarbazine, Prednisone, Epirubicin, Bleomycin, Vinblastine, CCNU (Lomustine), Adriamycin (Doxorubicin), DVA (Vindesine)

Regimen

Chemotherapy

Glucocorticoid therapy

MPP

MPP: Melphalan, Prednisone, Procarbazine

Regimen

Chemotherapy

Glucocorticoid therapy

MTP

MTP: Myocet (Non-pegylated liposomal doxorubicin), Trastuzumab, Paclitaxel

Regimen

Chemotherapy

Targeted therapy

MVC

MVC: Mitomycin, Vindesine, Carboplatin

Regimen

Chemotherapy

Neratinib & Paclitaxel

Regimen

Targeted therapy

Chemotherapy

Nimustine, Procarbazine, RT

Regimen

Chemotherapy

Radiotherapy

Nintedanib monotherapy

Regimen

Targeted therapy

NIP

NIP: Navelbine (Vinorelbine), Ifosfamide, Platinol (Cisplatin)

Regimen

Chemotherapy

Niraparib & Dostarlimab

Regimen

Immunotherapy

Targeted therapy

Niraparib & Pembrolizumab

Regimen

Immunotherapy

Targeted therapy

Nolatrexed monotherapy

Regimen

Chemotherapy

Paclitaxel & Atezolizumab

Regimen

Chemotherapy

Immunotherapy

Paclitaxel & Pertuzumab

Regimen

Chemotherapy

Targeted therapy

Paclitaxel & Sunitinib

Regimen

Chemotherapy

Targeted therapy

Paclitaxel & Trastuzumab (TH) & Everolimus

TH & Everolimus: Taxol (Paclitaxel), Herceptin (Trastuzumab), Everolimus

Regimen

Chemotherapy

Targeted therapy

Paclitaxel & Trebananib

Regimen

Chemotherapy

Targeted therapy

Palbociclib & Tamoxifen

Regimen

Endocrine therapy

Targeted therapy

Panitumumab & RT

Regimen

Targeted therapy

Radiotherapy

Pazopanib/Everolimus

Regimen

Targeted therapy

PD & Pembrolizumab

PD & Pembrolizumab: Pomalidomide, Dexamethasone, Pembrolizumab

Regimen

Study Dates of enrollment Evidence Comparator Comparative Efficacy
Mateos et al. 2019 (KEYNOTE-183) 2016-2017 Phase 3 (E-esc) PD Seems to have inferior PFS
(HR 1.53, 95% CI 1.05-2.22)

Targeted therapy

Glucocorticoid therapy

Immunotherapy

Pegylated liposomal doxorubicin & Trebananib

Regimen

Study Dates of enrollment Evidence Comparator Comparative Efficacy
Marth et al. 2016 (TRINOVA-2) 2011-2013 Phase 3 (E-esc) PLD Did not meet primary endpoint of PFS
(HR 0.92, 95% CI 0.68-1.24)

Chemotherapy

Targeted therapy

PEI

PEI: Platinol (Cisplatin), Etoposide, Ifosfamide

Regimen

Chemotherapy

PELF

PELF: Platinol (Cisplatin), Epirubicin, Leucovorin, 5-FU

Regimen

Chemotherapy

Pembrolizumab & RT

Regimen

Immunotherapy

Radiotherapy

Pemetrexed & Cetuximab

Regimen

Chemotherapy

Targeted therapy

Pemetrexed & Vandetanib

Regimen

Chemotherapy

Targeted therapy

PGT

PGT: Platinol (Cisplatin), Gemcitabine, Taxol (Paclitaxel)

Regimen

Chemotherapy

PGV

PGV: Platinol (Cisplatin), Gemcitabine, Vinorelbine
CGV: Cisplatin, Gemcitabine, Vinorelbine

Regimen

Chemotherapy

Pixantrone & Rituximab

Regimen

Chemotherapy

Targeted therapy

Pravastatin & Sorafenib

Regimen

Chemotherapy

Targeted therapy

Procarbazine & RT

Regimen

Chemotherapy

Radiotherapy

PVI

PVI: Platinol (Cisplatin), Vindesine, Ifosfamide
VIP: Vindesine, Ifosfamide, Platinol (Cisplatin)

Regimen

Chemotherapy

R-BEACOPP

R-BEACOPP: Rituximab, Bleomycin, Etoposide, Adriamycin (Doxorubicin), Cyclophosphamide, Oncovin (Vincristine), Procarbazine, Prednisone

Regimen

Targeted therapy

Chemotherapy

Glucocorticoid therapy

R-MegaCHOEP

R-MegaCHOEP: Rituximab, high-dose (Mega) Cyclophosphamide, Hydroxydaunorubicin (Doxorubicin), Oncovin (Vincristine), Etoposide, Prednisone

Targeted therapy

Chemotherapy

Glucocorticoid therapy

Realgar-Indigo naturalis formulation monotherapy

Regimen

Targeted therapy

Semustine & RT

Regimen

Chemotherapy

Radiotherapy

Sorafenib & Atezolizumab

Regimen

Immunotherapy

Targeted therapy

Tamoxifen & Everolimus

Regimen

Endocrine therapy

Targeted therapy

Tamoxifen & RT

Regimen

Endocrine therapy

Radiotherapy

TCG

TCG: Taxol (Paclitaxel), Carboplatin, Gemcitabine

Regimen

Chemotherapy

TCHL (Docetaxel)

TCHL: Taxotere (Docetaxel), Carboplatin, Herceptin (Trastuzumab), Lapatinib

Regimen

Chemotherapy

Targeted therapy

TCL (Docetaxel)

TCL: Taxotere (Docetaxel), Carboplatin, Lapatinib

Regimen

Chemotherapy

Targeted therapy

TEC

TEC: Taxol (Paclitaxel), Epirubicin, Carboplatin

Regimen

Chemotherapy

Temozolomide, Bevacizumab, RT

Regimen

Chemotherapy

Targeted therapy

Radiotherapy

Temozolomide, Nivolumab, RT

Regimen

Chemotherapy

Immunotherapy

Radiotherapy

Teniposide & RT

Regimen

Chemotherapy

Radiotherapy

Tipifarnib monotherapy

Regimen

Targeted therapy

Tivantinib monotherapy

Regimen

Targeted therapy

TPCV

TPCV: Thioguanine, Procarbazine, CCNU, Vincristine

Regimen

Chemotherapy

VAC & RT

Regimen

Chemotherapy

Radiotherapy

VADx

VADx: Vincristine, Ara-C (Cytarabine), Dexamethasone

Regimen

Chemotherapy

Glucocorticoid therapy

VAPEC-B

VAPEC-B: Vincristine, Adriamycin (Doxorubicin), Prednisolone, Etoposide, Cyclophosphamide, Bleomycin

Regimen

Chemotherapy

Glucocorticoid therapy

VBM (Vinblastine)

VBM: Vinblastine, Bleomycin, Methotrexate

Regimen

Chemotherapy

VCE

VCE: Vincristine, Carboplatin, Etoposide

Regimen

Chemotherapy

Vinorelbine & Hydrocortisone

Regimen

Chemotherapy

Endocrine therapy

VNC

VNC: Vincristine, Novantrone (Mitoxantrone), Cyclophosphamide

Regimen

Chemotherapy

VPV

VPV: Vinblastine, Platinol (Cisplatin), VP-16 (Etoposide)

Regimen

Chemotherapy

VTDC

VTDC: Velcade (Bortezomib), Thalidomide, Dexamethasone, Cyclophosphamide

Regimen

Targeted therapy

Glucocorticoid therapy

Chemotherapy